Curtin Medical School, Curtin University, GPO Box U1987, 6845, Perth, Western Australia.
Department of Pharmacy, Perth Children's Hospital, 6009, Perth, Western Australia.
J Cancer Educ. 2022 Oct;37(5):1553-1561. doi: 10.1007/s13187-022-02196-2. Epub 2022 Jul 22.
Pharmacists have a critical consulting role in patients undergoing oral antineoplastic drug therapy to ensure harm minimisation. Studies exploring the benefits of pharmacists in this role are limited. This study evaluated patient perceptions, experiences and overall satisfaction with clinical pharmacist consultations in patients treated with oral antineoplastic drugs. Data on 160 patients initiated on oral antineoplastic drugs between January 2019 and February 2021 were collected retrospectively from an outpatient Comprehensive Cancer Centre of a quaternary hospital in Western Australia (demographics, cancer type, oral antineoplastic drugs prescribed). In addition, patients were mailed a hard copy questionnaire in March 2021 to assess their satisfaction with pharmacist consultations in the pharmacist clinic, using a 5-point Likert scale. The statements included perceptions of the patient's understanding, medication adherence, experiences and overall satisfaction with the clinical pharmacist consultation. There were 76 (47.5%) completed questionnaires returned (52.6% female; average age was 63.2 ± 13.9 years). The majority of patients were satisfied with the service offered by the clinical pharmacist (73/76; 96.1%), perceived that clinical pharmacists provided an important service in outpatient cancer care (71/76; 93.4%) and improved their understanding of the use of oral antineoplastic drugs and side-effect management (48/74; 64.9%). Patients' perceived understanding of their medication regimen and additional health services available improved after pharmacist counselling. The patients also reported overall satisfaction with the service provided by the clinical pharmacist and found it beneficial to their care. The study supports the expanding role of the clinical pharmacist in an outpatient cancer centre.
药剂师在接受口服抗肿瘤药物治疗的患者中具有关键的咨询作用，以确保将伤害最小化。探索药剂师在这一角色中的益处的研究有限。本研究评估了患者对口服抗肿瘤药物治疗患者的临床药师咨询的看法、经验和总体满意度。从澳大利亚西部一家四等医院的门诊综合癌症中心回顾性收集了 2019 年 1 月至 2021 年 2 月期间开始接受口服抗肿瘤药物治疗的 160 名患者的数据（人口统计学、癌症类型、开具的口服抗肿瘤药物）。此外，2021 年 3 月向患者邮寄了一份纸质问卷，使用 5 分李克特量表评估他们对药师诊所中药师咨询的满意度。这些陈述包括对患者理解、药物依从性、体验和对临床药师咨询的总体满意度的看法。共收回 76 份（52.6%为女性；平均年龄为 63.2±13.9 岁）完整的问卷。大多数患者对临床药师提供的服务感到满意（73/76；96.1%），认为临床药师在门诊癌症护理中提供了重要服务（71/76；93.4%），并提高了他们对口服抗肿瘤药物的使用和副作用管理的理解（48/74；64.9%）。在药师咨询后，患者对其药物治疗方案的理解和额外可获得的健康服务的感知有所改善。患者还报告对临床药师提供的服务总体满意，并发现这对他们的治疗有益。该研究支持临床药师在门诊癌症中心扩大作用。
